Worms under stress: C. elegans stress response and its relevance to complex human disease and aging

Trends in Genetics

Volumn 29, Issue 6, 2013, Pages 367-374

  Rodriguez, Miriam ^a   Basten Snoek, L ^a   De Bono, Mario ^b   Kammenga, Jan E ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

C. elegans; Complex human disease; Daf 16; Hsf 1

Indexed keywords

CARBON DIOXIDE; HYPOXIA INDUCIBLE FACTOR 1; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

AGING; ALZHEIMER DISEASE; CAENORHABDITIS ELEGANS; DRUG DESIGN; ENVIRONMENTAL STRESS; GENE EXPRESSION; HEAT SHOCK; HEAT SHOCK RESPONSE; HYPEROSMOTIC STRESS; HYPOXIA; NEOPLASM; NONHUMAN; OSMOTIC STRESS; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

AGING; ANIMALS; ANOXIA; CAENORHABDITIS ELEGANS; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; HEAT-SHOCK RESPONSE; HUMANS; OXIDATIVE STRESS; STRESS, PHYSIOLOGICAL;

CAENORHABDITIS ELEGANS;

EID: 84878199302     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2013.01.010     Document Type: Review

References (97)

1. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77:71-94.
2. Antoshechkin I., Sternberg P.W. The versatile worm: genetic and genomic resources for Caenorhabditis elegans research. Nat. Rev. Genet. 2007, 8:518-532.
3. Xu X., Kim S.K. The early bird catches the worm: new technologies for the Caenorhabditis elegans toolkit. Nat. Rev. Genet. 2011, 12:793-801.
4. Snoek L.B., et al. WormQTL - public archive and analysis web portal for natural variation data in Caenorhabditis spp. Nucleic Acids Res. 2013, 41:D738-D743.
5. Félix M.A., Barkoulas M. Robustness and flexibility in nematode vulva development. Trends Genet. 2012, 28:185-195.
6. Kaletta T., Hengartner M.O. Finding function in novel targets: C. elegans as a model organism. Nat. Rev. Drug Discov. 2006, 5:387-398.
7. Markaki M., Tavernarakis N. Modeling human diseases in Caenorhabditis elegans. Biotechnol. J. 2010, 5:1261-1276.
8. Kenyon C. A pathway that links reproductive status to lifespan in Caenorhabditis elegans. Ann. N. Y. Acad. Sci. 2010, 1204:156-162.
9. Christensen K., et al. The quest for genetic determinants of human longevity: challenges and insights. Nat. Rev. Genet. 2006, 7:436-448.
10. Fuchs Y., Steller H. Programmed cell death in animal development and disease. Cell 2011, 147:742-758.
11. Calahorro F., Ruiz-Rubio M. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder. Invert. Neurosci. 2011, 11:73-83.
12. De Deyn P.P., et al. Caenorhabditis elegans as a model organism for dementia. Animal Models of Dementia 2011, 241-253. Humana Press. P.P. De Deyn, D. Van Dam (Eds.).
13. Harrington A.J., et al. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease. Dev. Dyn. 2010, 239:1282-1295.
14. Kirienko N.V., Fay D.S. SLR-2 and JMJC-1 regulate an evolutionarily conserved stress-response network. EMBO J. 2010, 29:727-739.
15. Rea S.L., et al. Bacteria, yeast, worms, and flies: exploiting simple model organisms to investigate human mitochondrial diseases. Dev. Disabil. Res. Rev. 2010, 16:200-218.
16. Wiese M., et al. Intracellular trafficking and synaptic function of APL-1 in Caenorhabditis elegans. PLoS ONE 2010, 5:e12790.
17. Benian G.M., Epstein H.F. Caenorhabditis elegans muscle: a genetic and molecular model for protein interactions in the heart. Circ. Res. 2011, 109:1082-1095.
18. Lant B., Storey K.B. An overview of stress response and hypometabolic strategies in Caenorhabditis elegans: conserved and contrasting signals with the mammalian system. Int. J. Biol. Sci. 2010, 6:9-50.
19. Hsu A.L., et al. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 2003, 300:1142-1145.
20. Anckar J., Sistonen L. Heat shock factor 1 as a coordinator of stress and developmental pathways. Adv. Exp. Med. Biol. 2007, 594:78-88.
21. Sendoel A., et al. HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase. Nature 2010, 465:577-583.
22. Prahlad V., et al. Regulation of the cellular heat shock response in Caenorhabditis elegans by thermosensory neurons. Science 2008, 320:811-814.
23. Prahlad V., Morimoto R.I. Integrating the stress response: lessons for neurodegenerative diseases from C. elegans. Trends Cell Biol. 2009, 19:52-61.
24. Morimoto R.I. The heat shock response: systems biology of proteotoxic stress in aging and disease. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:91-99.
25. Kourtis N., et al. Small heat-shock proteins protect from heat-stroke-associated neurodegeneration. Nature 2012, 490:213-218.
26. Volovik Y., et al. Temporal requirements of heat shock factor-1 for longevity assurance. Aging Cell 2012, 11:491-499.
27. Chiang W.C., et al. HSF-1 regulators DDL-1/2 link insulin-like signaling to heat-shock responses and modulation of longevity. Cell 2012, 148:322-334.
28. Willcox B.J., et al. FOXO3A genotype is strongly associated with human longevity. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:13987-13992.
29. Flachsbart F., et al. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2700-2705.
30. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 2008, 8:915-928.
31. Strassburger K., et al. Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP. Dev. Biol. 2012, 367:187-196.
32. Westerheide S.D., et al. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 2009, 323:1063-1066.
33. Yi J., Luo J. SIRT1 and p53, effect on cancer, senescence and beyond. Biochim. Biophys. Acta 2010, 1804:1684-1689.
34. Mendillo M.L., et al. HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell 2012, 150:549-562.
35. Alavez S., et al. Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature 2011, 472:226-229.
36. Hartl F.U., et al. Molecular chaperones in protein folding and proteostasis. Nature 2011, 475:324-332.
37. Moran J.M., et al. Nitric oxide in paraquat-mediated toxicity: a review. J. Biochem. Mol. Toxicol. 2010, 24:402-409.
38. Samann J., et al. Caenorhabditits elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth. J. Biol. Chem. 2009, 284:16482-16491.
39. Thomas B., Beal M.F. Parkinson's disease. Hum. Mol. Genet. 2007, 16:R183-R194.
40. Hoekstra A.S., Bayley J.P. The role of complex II in disease. Biochim. Biophys. Acta Bioenerg. 2012, 10.1016/j.bbabio.2012.11.005.
41. Ishii T., et al. Model animals for the study of oxidative stress from complex II. Biochim. Biophys. Acta Bioenerg. 2012, 10.1016/j.bbabio.2012.11.016.
42. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 1997, 3:177-182.
43. Jiang H., et al. The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS protein that is required for adaptation to hypoxia. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:7916-7921.
44. Yu R., et al. Association of HIF-1alpha expression and cell apoptosis after traumatic brain injury in the rat. Chin. J. Traumatol. 2001, 4:218-221.
45. Hsu T. Complex cellular functions of the von Hippel-Lindau tumor suppressor gene: insights from model organisms. Oncogene 2012, 31:2247-2257.
46. Bretscher A.J., et al. A carbon dioxide avoidance behavior is integrated with responses to ambient oxygen and food in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:8044-8049.
47. Li Y., et al. HUMMR, a hypoxia- and HIF-1alpha-inducible protein, alters mitochondrial distribution and transport. J. Cell Biol. 2009, 185:1065-1081.
48. Benizri E., et al. The magic of the hypoxia-signaling cascade. Cell. Mol. Life Sci. 2008, 65:1133-1149.
49. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
50. Hoppe T. Too salty for worms: hypertonic stress challenges proteostasis networks. Focus on 'Hypertonic stress induces rapid and widespread protein damage in C. elegans'. Am. J. Physiol. Cell Physiol. 2011, 301:C555-C556.
51. Burkewitz K., et al. Hypertonic stress induces rapid and widespread protein damage in C. elegans. Am. J. Physiol. Cell Physiol. 2011, 301:C566-C576.
52. Rohlfing A.K., et al. The Caenorhabditis elegans mucin-like protein OSM-8 negatively regulates osmosensitive physiology via the transmembrane protein PTR-23. PLoS Genet. 2011, 7:e1001267.
53. Shaye D.D., Greenwald I. OrthoList: a compendium of C. elegans genes with human orthologs. PLoS ONE 2011, 6:e20085.
54. Fukushige T., et al. The GATA-factor elt-2 is essential for formation of the Caenorhabditis elegans intestine. Dev. Biol. 1998, 198:286-302.
55. Moronetti Mazzeo L.E., et al. Stress and aging induce distinct polyQ protein aggregation states. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:10587-10592.
56. Dossena S., et al. The molecular and functional interaction between ICln and HSPC038 proteins modulates the regulation of cell volume. J. Biol. Chem. 2011, 286:40659-40670.
57. +/myo-inositol transporter genes, hmit-1.1 and hmit-1.2, have roles in the osmoprotective response in Caenorhabditis elegans. Biochem. Biophys. Res. Commun. 2011, 410:471-477.
58. Lamitina T., et al. Genome-wide RNAi screening identifies protein damage as a regulator of osmoprotective gene expression. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12173-12178.
59. Selkoe D.J. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat. Cell Biol. 2004, 6:1054-1061.
60. Alavez S., Lithgow G.J. Pharmacological maintenance of protein homeostasis could postpone age-related disease. Aging cell 2012, 11:187-191.
61. Nagai Y., et al. Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases. Curr. Pharm. Biotechnol. 2010, 11:188-197.
62. Balch W.E., et al. Adapting proteostasis for disease intervention. Science 2008, 319:916-919.
63. Calamini B., et al. Small-molecule proteostasis regulators for protein conformational diseases. Nat. Chem. Biol. 2012, 8:185-196.
64. Morley J.F., et al. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:10417-10422.
65. Auluck P.K., et al. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 2002, 295:865-868.
66. Whitesell L., Lindquist S. Inhibiting the transcription factor HSF1 as an anticancer strategy. Expert Opin. Ther. Targets 2009, 13:469-478.
67. Bosch-Marce M., et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ. Res. 2007, 101:1310-1318.
68. Rey S., et al. Synergistic effect of HIF-1alpha gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20399-20404.
69. Majmundar A.J., et al. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 2010, 40:294-309.
70. Morley J.F., Morimoto R.I. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol. Biol. Cell 2004, 15:657-664.
71. Vertino A., et al. A narrow quantitative trait locus in C. elegans coordinately affects longevity, thermotolerance, and resistance to paraquat. Front. Genet. 2011, 2:63.
72. Knoefler D., et al. Quantitative in vivo redox sensors uncover oxidative stress as an early event in life. Mol. Cell 2012, 47:767-776.
73. Park E.C., et al. Hypoxia regulates glutamate receptor trafficking through an HIF-independent mechanism. EMBO J. 2012, 31:1379-1393.
74. Tissenbaum H.A. Genetics, life span, health span, and the aging process in Caenorhabditis elegans. J. Gerontol. A: Biol. Sci. Med. Sci. 2012, 67:503-510.
75. Yen K., et al. DAF-16/Forkhead box O transcription factor: many paths to a single Fork(head) in the road. Antioxid. Redox Signal. 2011, 14:623-634.
76. Anckar J., Sistonen L. Regulation of HSF1 function in the heat stress response: implications in aging and disease. Annu. Rev. Biochem. 2011, 80:1089-1115.
77. Doonan R., et al. Against the oxidative damage theory of aging: superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegans. Genes Dev. 2008, 22:3236-3241.
78. Fujii M., et al. Mutation in a mitochondrial ribosomal protein causes increased sensitivity to oxygen with decreased longevity in the nematode Caenorhabditis elegans. Genes Cells 2011, 16:69-79.
79. Fujii M., et al. A mutation in a mitochondrial dehydrogenase/reductase gene causes an increased sensitivity to oxidative stress and mitochondrial defects in the nematode Caenorhabditis elegans. Genes Cells 2011, 16:1022-1034.
80. Jaubert J., et al. Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). Proc. Natl. Acad. Sci. U.S.A. 1999, 96:10278-10283.
81. Mok C.A., et al. Mutations in a guanylate cyclase GCY-35/GCY-36 modify Bardet-Biedl syndrome-associated phenotypes in Caenorhabditis elegans. PLoS Genet. 2011, 7:e1002335.
82. Young R.M., Simon M.C. Untuning the tumor metabolic machine: HIF-alpha: pro- and antitumorigenic?. Nat. Med. 2012, 18:1024-1025.
83. Zhuang Z., et al. Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N. Engl. J. Med. 2012, 367:922-930.
84. Chintala S., et al. Prolyl hydroxylase 2 dependent and Von Hippel-Lindau independent degradation of hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition. BMC Cancer 2012, 12:293.
85. Basel-Vanagaite L., et al. Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1. Am. J. Hum. Genet. 2012, 90:49-60.
86. Allen H.L., et al. GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nat. Genet. 2012, 44:20-22.
87. Zhang W., et al. GATA4 mutations in 486 Chinese patients with congenital heart disease. Eur. J. Med. Genet. 2008, 51:527-535.
88. Kammenga J.E., et al. Beyond induced mutants: using worms to study natural variation in genetic pathways. Trends Genet. 2008, 24:178-185.
89. Rodriguez M., et al. Genetic variation for stress-response hormesis in C. elegans lifespan. Exp. Gerontol. 2012, 47:581-587.
90. Gutteling E.W., et al. Environmental influence on the genetic correlations between life-history traits in Caenorhabditis elegans. Heredity 2007, 98:206-213.
91. Jonker M.J., et al. Toxicity of simple mixtures to the nematode Caenorhabditis elegans in relation to soil sorption. Environ. Toxicol. Chem. 2004, 23:480-488.
92. Kammenga J.E., et al. A Caenorhabditis elegans wild type defies the temperature-size rule owing to a single nucleotide polymorphism in tra-3. PLoS Genet. 2007, 3:358-366.
93. McGrath P.T., et al. Quantitative mapping of a digenic behavioral trait implicates globin variation in C. elegans sensory behaviors. Neuron 2009, 61:692-699.
94. Viñuela A., et al. Genome-wide gene expression regulation as a function of genotype and age in C. elegans. Genome Res. 2010, 20:929-937.
95. Viñuela A., et al. Genome-wide gene expression analysis in response to organophosphorus pesticide chlorpyrifos and diazinon in C. elegans. PLoS ONE 2010, 5:e12145.
96. Viñuela A., et al. Aging uncouples heritability and expression-QTL in Caenorhabditis elegans. G3 (Bethesda) 2012, 2:597-605.
97. de Bono M., Bargmann C.I. Natural variation in a neuropeptide Y receptor homolog modifies social behavior and food response in C. elegans. Cell 1998, 94:679-689.